Large Pharmaceutical Company in China Selects TrialMaster® EDC and Acuity Analytics for Major Clinical Study
In a milestone transaction, a major pharmaceutical company based in China will undertake a multisite clinical study using TrialMaster EDC...
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza
BioNTech AG, a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease, announced...
Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
Teva Pharmaceutical Industries Ltd. and Regeneron Pharmaceuticals, Inc. announced positive topline results from a Phase 3, randomized, double-blind, placebo-controlled study...
NIH begins clinical trial of live, attenuated Zika vaccine
Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the...
FDA approves first generic version of EpiPen
The U.S. FDA approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of...
Mount Sinai Researchers Discover How to Restore Vision Using Retinal Stem Cells
Researchers at Mount Sinai have successfully restored vision in mice through activating retinal stem cells, something that has never been...
Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer
An interim analysis of data from a randomized clinical trial of patients with human papillomavirus (HPV)-positive oropharyngeal cancer found that...
FDA approves new treatment for a rare genetic disorder, Fabry disease
The U.S. FDA approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug...
TraceLink Announces Russia Compliance Solution, Designed to Meet Complex Track and Trace Requirements for Customers Supplying to Russian Market
TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information...
BD Drives the Future of Immunology Research with Expanded Offerings for Simultaneous RNA and Protein Expression Analysis
BD , a leading global medical technology company, announced the commercial release of the BD™ AbSeq assay to analyze protein...
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.